Nomenclature of steroids (Recommendations 1989)
The recommendations of steroid nomenclature have a long history, a brief account of which was given in definitive rules for the nomenclature of steroids (1971) [l] . Since that time, many of the principles developed for the nomenclature of steroids have been generally adopted and have become part of the IUPAC nomenclature of organic compounds, especially section F [3] . The aim of the present document, prepared with the help of a panel of experts, is a revision of the recommendations in the light of new developments and current practice.
The main changes are as follows: (i) modifications, where appropriate, to conform to section F (Natural Products) of the IUPAC nomenclature [3] ; (ii) a wider use of the RS system for designating the stereochemistry in the side chain; (iii) the incorporation of the new recommendations (1981) for the nomenclature of vitamin D [5] ; and (iv) the omission of most steroid alkaloid and steroid-like triterpenoids as it is intended that they should be treated in an appendix to IUPAC nomenclature, section F [3] . Significant changes are indicated by A in the margin for major additions and A for minor revisions. These recommendations are numbered 3s-1, 3s-2, 3s-3, etc., the initial 3 denoting that this is the third revised set of recommendations. 3s-1. GENERAL A 3s-1.0.
Definition of steroids and sterols
Steroids are compounds possessing the skeleton of cyclopenta[a]phenanthrene or a skeleton derived therefrom by one or more bond scissions or ring expansions or contractions. Methyl groups are normally present at C-10 and C-13. An alkyl side chain may also be present at C-17. Sterols are steroids carrying a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain.
This definition of sterols is rather restrictive. However, a less restrictive definition would cause difficulties, e.g. androst-16-en-3p-01 is normally not called a sterol and should not fall under the definition. 3s-1.1. Numbering and ring letters Steroids are numbered and rings are lettered as in formula 1. If one of the two methyl groups attached to C-25 is substituted it is assigned the lower number (26); if both are substituted, that carrying the substituent cited first in the alphabetical order is assigned the lower number. For trimethyl steroids see Recommendation 38-2.4, Note 2. (1) A Note
A Note
The numbers 28, 29 and 30 are now assigned to the additional methyl groups at C-4 and C-14 in mterpenoids, e.g. lanosterol (see 33-2.4, note 2) . Therefore, the carbon atoms at the methyl or ethyl groups at C-24 had to be renumbered. The system adopted here allows also numbering of other carbon atoms attached to the steroid skeleton. If two side chains are attached to the same carbon atom, the shorter one receives primed numbers, e.g. 17l' (see 33-2.7 and 38-2.8).
3s-1.2. Absent carbon atoms
If one or more of the carbon atoms shown in 1 is not present and a steroid name is used, the numbering of the remainder is undisturbed. 3s-1.3.
Absolute configuration
The absolute stereochemistry of a steroid is defined by the parent name for some chiral centres (see 3s-1.5) and by a, p, R or S for other centres (see 3s-1.4 and 3s-1.6). When the configuration at one or more centres is not known, this is indicated by the Greek letter(s) 5 (xi) prefixed by the appropriate locant(s).
3s-1.4. Orientation of projection formulae
When the rings of a steroid are denoted as projections onto the plane of the paper, the formula is normally to be &awl as in 20. An a m or ~o u p attached to a M g depicted as in the orientation 2 1 is renmd EI (dpbs) if it lies below the plane of the paper or p (beta) if it lies above the plane of the paper. In formulae, bonds to atoms or groups lying below the plane of the paper (a) are shown as broken lines ( ------o r~~~l l~~) , and bonds to atoms or groups lying above the plane of the paper @) are shown as solid lines (preferably thickened,-or -). Bonds to atoms or groups whose configuration is not known are denoted by wavy lines ( ---).
R

Notes
1) In the formula 2a given above, all angular methyl groups and H atoms have been written out explicitly. However, when there is no ambiguity, methyl groups may also be indicated by a bond without lettering as in 2b, a practice followed in other fields. Likewise, the hydrogen atoms at the bridgehead (2-8, C-9 and C-14 may be omitted if there is no ambiguity, i.e. if they are oriented 88,9a,14a. If one of the hydrogen atoms is replaced, e.g. by a fluorine atom, care must be taken in the correct use of broken ( a ) and bold (p) lines. The bond to a bridgehead hydrogen atom should never be drawn without the H.
2) Projections of steroid formulae should not be oriented as in formulae 2c, 2d or 2e unless circumstances make it obligatory, e.g. in dimers formed photochemically [4] .
A (2c)
(2d) (2e) 3) With the preferred orientation 2a, and with 2c, which is only rotated in the plane of the paper, a-bonds appear as broken lines and 8-bonds as solid (thickened) lines. The reverse is true for 2d and 2e; therefore, orientation 2c is preferred over 2d or 2e if there is a choice. Wavy lines denote {-bonds for all orientations of the formula.
Example: 3,3'-Bicholesta-3,5-diene should be represented as 3a but not as 3b.
C6H I7 4) A perspective representation of the stereochemistry of formula 2 as in 2f or 2g may also be used:
A Spsteroid (20 A 5a-steroid When steroid formulae are drawn in this way, bonds pointing upwards are, by convention, drawn bold and bonds pointing downwards are drawn broken; these representations correspond to the p-and a-bonds of projection formulae such as 2a and do not conform to the general practice that bold and broken lines denote bonds projecting respectively above and below the plane of the paper. Note, however, that the general practice is followed with chair and boat forms of spirostans (see Recommendation 38-3.3).
5) To save space and to emphasise the relevant portion of the steroid formula a brace may be used. For example 2h only shows ring D and the side chain at C-17 but in this context the portion to the left of the brace may be assumed to be the rest of an androstane ring system as in formulae 2a-g. In other contexts, for example, it might represent the rest of an estrane ring system, including any substituents, and double bonds present in that portion.
Stereochemistry of ring junctions and side-chain attachment
Unless implied or stated to the contrary (see Recommendations 3s-3, 3s-4.1 and 3S-5), use of a steroid name implies that atoms or groups attached at the bridgehead positions 8, 9, 10, 13 and 14 are oriented as shown in formula 2a (i.e. 8p, 9a, lOp, l3p, 14a) , and a side chain attached at position 17 is assumed to be p-oriented (see notes below). The configuration of hydrogen (or a substituent) at the bridgehead position 5 is always to be designated by adding a, p or 6 after the numeral 5, this numeral and letter being placed immediately before the stem name, The stereochemistry of substituents attached to the tetracyclic system A-D is stated by adding a, p or 5 after the respective numerals denoting their position. Notes the stereochemistry, e.g. 9a-fluoro-5a-pregnane instead of 9-fluoro-5a-pregnane. The stereochemistry of substituents on the steroid side chain is described by the sequence rule procedure (see A 3s-1.6. Stereochemistry of substituents in the side chain [3] , section E), unless implied by the name (see 38-2.4 and 
(24S)-24-Methyl-5a-cholestan-3/3-ol or 5a-ergostan-3pol The backbone of a side chain at C-17 is best denoted as in the plane of the paper (lines of ordinary thickness), the 17-20 bond being similarly denoted. Stereochemistry due to substituents on the chain is then indicated by the customary thick or broken lines denoting bonds that project, respectively, above and below the A plane of the paper. In formulae the representation of the side chain is drawn as in examples 6 and 7 in preference to those used in the previous edition of this document [l] .
2) In the pregnane series, the stereochemistry at C-20 was formerly designated as 20a or 20p. This convention was based on a Fischer projection with the highest number at the top, as given in formula 8. This nomenclature is A now discouraged for specific compounds in favour of the R,S system, which can be generally used for all chiral centres in the side chain(s). However, as a and P are independent of substituents at neighbouring atoms they are retained for the corresponding enzyme names, e.g. 20a-hydroxysteroid dehydrogenase. The parent tetracyclic hydrocarbon without methyl groups at C-10 and C-13 and without a side chain at C-17 is
C-17 is named estrane (alternative spelling: oestrane), as shown in 11 and 12.
The hydrocarbon with a methyl group at C-13 but without a methyl group at C-10 and without a side chain at The hydrocarbon with methyl groups at C-10 and (2-13 but without a side chain at C-17 is named androstane 13
Sp Androstane
Note
For the names of hydrocarbons having a methyl group attached to C-10 and a hydrogen atom attached to C-13, or compounds where an ethyl group replaces a methyl group, see 3s-6. Ring expansion or contraction is covered by 3s-7. 
20R
Sa-cholane Spcholane (not allocholane)
Sa-cholestane SP-cholestane (not coprostane)
20R,24S
Sa-ergostane Sfl-ergostane
20R,24R
Sa-campestane Spcampestane
20R ,249
Sa-poriferastane Spporiferastane
20R,24R
Sa-stigmastane Spstigmastane
20S,22R,23R,24R
Sa-gorgostane Spgorgostane
23
H3C
CH3 CH3
33-2.4. Parent hydrocarbons with side chain at C-I 7
are listed in Table 1 .
The names used for the hydrocarbons 15 and 16 with methyl groups at both C-10 and C-13 and a side chain R &-H 10 &-H 10
The names of the hydrocarbons given in Table 1 imply the configuration at the chiral centres in the side chain as given in the second column. The conventions of the sequence rule, however, mean that R may change to S without a change at the relevant atom when there is a change in the substitution or unsaturation, e.g. compare 6
and 7.
2) Some tetracyclic triterpenoids may be regarded as trimethyl steroids, the three additional methyl groups being numbered 28 (attached to C-4 with a-configuration), 29 (attached to C-4 with P-configuration) and 30 (attached to (2-14); this numbering corresponds to that used for the triterpenoids. This type of nomenclature is especially useful for the parent hydrocarbons of biogenetic precursors of steroids. For .example, lanostane 17 is 4,4,14-trimethyl-5a-cholestane, the former name implying the 5a,8P,9a,lOP, 13B,14a,17P,20R configuration. The change of configuration at C-9 in cycloartane 18 is implied in the name, although it must be specified if called 4,4,14-trimethy1-9,19-cyclo-5a,9gcholestane. 
4,4,14-Trimethyl-9,19-cyclo-5~9~cholestane
or cycloartane 3) For the names of hydrocarbons that are related to those given in Table 1 by the addition or removal of one or more carbon atoms, see 3s-6. For ring expansion or contraction see 3s-7. 3 8 -2 5 Unsaturation Examples:
Unsaturation is indicated by changing -ane to -ene, -adiene, -yne etc., or -an-to -en-, -adien-, -yn-etc.
Androst-5-ene, not 5-androstene 5a-Cholest-6-ene 5PCholesta-7,9( 1 1)-diene 5a-Cholest-6-en-3P-01 
38-2.6. Stereochemistry of double bonds
The stereochemistry of double bonds in the side chain should be indicated using the E,Z convention (cf. Recommendation E-2.2 in [3] ). The same applies to the seco compounds of the vitamin D series (see . Example:
cf. also formula 7
38-2.7. Steroids with a side chain as part of the parent carbocycle and an alkyl substituent at C-17
If a steroid has two carbon chains attached at position 17 and one of them is included in Table 1 , the compound is named as a 17-alkyl derivative of that steroid. If both side chains at C-17 are in Table 1 , then the larger one is used, or the one in the normal configuration, e.g. 17-ethyl-5a-cholestane, 17-ethyl-5a-pregnane (not 17-ethyl-A -5a,l7a-pregnane). The carbon atoms of the alkyl substituent may be numbered by a superscript number added to the number of the atom to which it is attached, e.g. 17l, 17 *... etc. (cf. example 26). Examples:
Locants with superscript numbers are intended for the identification of the atoms e.g. in 13C-nmr spectral assignments, not as locants for further substitution e.g. oxymetholone [an international non-proprietary name (INN) see 3s-4.10 and Appendix] is 17~hydroxy-2-(hydroxymethylene)-17a-methyl-5a-androstan-3-one, not 2l, 17pdihydroxy-17a-methyl-2-methylene-5a-androstan-3-one.
38-2.8. Steroids with two alkyl substituents at C-17
is named as a 17,17-disubstituted androstane. Examples:
If a steroid has two carbon chains attached at position 17, neither of which is included in Table 1 , the compound (27) 17,17-Dimethyl-5a-androstane (28) 17PMethyl-17a-propyl-5a-androstane Notes 1) Some steroids of this class can be related to a fundamental structure listed in Table 1 by applying the rules of chain lengthening and shortening (3s-6). Thus structure 28 could be called 17-methyl-21,24-dinor-5a, 17a-Gholane. This procedure is not recommended as it often yields cumbersome names.
2) The carbon atoms of the alkyl substituents may be numbered by a superscript number added to the number of the steroid skeletal atom to which it is attached. The shorter of the two substituent chains receives primed superscript numbers. If the two substituent chains are of equal length and attached to the steroid ring system the substituent on the B-face has primed superscript numbers. If the two substituent chains are attached to the side chain of the steroid and are of equal length but one is further substituted the other chain has primed superscript numbers. In the absence of further substitution the p r o 4 group has primed superscript numbers.
3) Locants with superscript numbers are intended for the identification of the atoms e.g. in 13C-nmr spectral assignments, not as locants for further substitution (see note to 38-2.7). 38-2.9. The former recommendation that the configuration at C-14 must always be stated as an affix is abandoned; 14fi is implied unless otherwise stated. See also note 1 to 3s-1.5. 
38-3.2. Bufanolides
The name bufanolide is used for the compound of structure 37, the parent compound of the squill-toad poison group of lactones, with the configurations 14/3,20R as shown implied in the name. Unsaturated derivatives are named by replacing the suffix -anolide by -enolide, -adienolide, etc.; thus the name bufa-20,22-dienolide is used for the naturally occurring doubly unsaturated lactones.
As with cardanolides, the recommendation to always state the configuration at C-14 is abandoned. See also note (1) to 3s-1.5. Examples: Although ring E, like rings A, B, C and D, can conveniently be shown by projection on to the plane of the paper, ring F cannot be adequately represented in this way since C-23, C-24 and (2-26 and the oxygen atom lie in a plane that is perpendicular to the plane of the paper. Ring F is conveniently drawn as in formulae 40-43; in formula 40, for instance, the broken line from C-22 to oxygen denotes that the oxygen atom and C-26 of ring F lie behind the plane of the paper and that consequently C-23 and C-24 lie in front of the plane of the paper (configuration R at C-22). In formula 41 the configuration at C-22 is reversed and must be stated in the name as 22s. It is conventional to draw ring F as a chair, but this conformation is not implied in the name spirostan. Whatever the conformation of ring F, C-27 and the 25-hydrogen atom may be considered to lie in the plane of the paper and so cannot be denoted by broken or thickened lines. In 42 the methyl group is axial (above the general plane of ring F), and in 41 it is equatorial (in the general plane of ring F).
2) The R,S specifcation may also be affected by substituents attached to ring F or C-27, as in compound 43 (cf. 42).
38-3.4. Furostans
The name furostan is used for the compound of structure 44 (16,22-epoxycholestane); this name specifies the configurations at all the asymmetric centres except position 5, 22 and (if position 26 is substituted) also 25.
Configuration at C-5 is designated by use of a or p in the usual way (see Recommendation 38-1.5), and configurations at C-22 and, if necessary, C-25 by the sequence-rule procedure, or in all these cases by 6 if unknown.
Substituents Table 1. case of unsaturated compounds, this ending is changed to -enine, -adienine, etc. as appropriate.
A special appendix to section F of ref. 3 dealing with these problems is in preparation.
3s-4.0. General
Nearly all biologically important steroids are derivatives of the parent hydrocarbons (cf. Table 1 ) carrying various functional groups. Their nomenclature follows the general recommendations of the nomenclature of organic compounds (Sections C and D in [3] ). However, there are some special problems in the application of these recommendations to natural products like steroids. Therefore, and for the benefit of the biochemist not so familiar with the recommendations of substitutive nomenclature, these are outlined and exemplified here. For full details, the reader is referred to the IUPAC Recommendations [3] .
Most substituents can be designated either as suffixes or prefixes; some, however, the commonest being halogens, alkyl groups (see 38-2.7 and 38-2.8) and alkoxy groups, can only be designated as prefixes. Lists of these two types are given in Tables I and II respectively section C-10 of [3] .
When possible, one type of substituent must be designated as suffix. When more than one type is present that could be designated as suffix only one type may be so expressed and the other types must be designated as prefixes. The choice for suffix is made according to an order of preference that is laid down in [3] ; the most important part of this order, for steroids, is as follows in decreasing preferences: onium salt, acid, lactone, ester, aldehyde, ketone, alcohol, amine.
Suffixes are added to the name of the saturated or unsaturated parent system (see 33-2.5), the terminal e of -ane, -ene, -yne, -adiene etc. being elided before a vowel (presence or absence of numerals has no effect on such elisions).
If systematic names for steroid alkaloids are desired, they should be derived from pregnane, cholestane or some Trivial names for the parent saturated structures of steroid alkaloids are so chosen that they end in -anine. In the An extensive treatment of the nomenclature of steroid alkaloids is beyond the scope of these recommendations.
3s-4. FUNCTIONAL GROUPS
IUPAC-IUB JOINT COMMISSION ON BIOCHEMICAL NOMENCLATURE
The following recommendations are on these principles. In this section, the formulae of examples correspond to 2b, i.e. the methyl groups are indicated by a bond without lettering, and the hydrogen atoms at (2-8, C-9 and (2-14 are omitted. 3s-4.1. Acids, salts and esters Acids, their salts and esters are generally named by use of suffixes. a) If a methyl group is changed into a carboxyl group, the suffix is -oic acid; it is preceded by the appropriate locant. In biochemical papers, these compounds are often named as anions, the counter-ion beiflg unspecified; in this case, the suffix is -0ate. Examples:
11 -0xo-5a-cho1an-24-oic acid -4~methyl-5a-cholesta-8,24-diene-4a- Diethyl5a-cholane-21,24-dioate
3~-Hydroxy
24-Methyl 3p-hydroxy-5a-cholane-21,24-dioate (51) Methyl 3-(3phydroxyandrost-4-en-16a-y1)propanoate 33-4.2. Lactones a) Lactones, other than cardanolides and bufanolides, are named by changing the ending -ic acid or -carboxylic acid of the name of the hydroxy acid to -1actone or -carbolactone respectively, preceded by the locant of the acid group and then the locant of the hydroxyl group. The lactonised hydroxyl group is not stated separately. Examples:
3~Hydroxy-5a-cholano-24,17-1actone In examples 53 and 54 the suffix carbolactone corresponds to a substituent with an additional carbon atom which is numbered accordingly (see 38-2.7). If example 53 was called 3~-hydroxy-23,24-dinorchol-5-eno--21,lS-lactone (name not recommended), then the lactone carbonyl would be C-21 (see 3s-6.2 for use of nor). Similarly, if example 54 was called 7a-acetylthio-3-oxo-2la-homo-17-pregn-4-eno-2la,l7-lactone (name not recommended), then the lactone carbonyl would be C-21a (see 3s-6.1 for use of homo). b) Cardanolides and bufanolides. The -olide ending of these names denotes the lactone grouping, and substituents must be named as prefixes.
38-4.3. Esters of steroid alcohols
Esters of steroid alcohols are named by the appropriate steroid substituent group followed by that of the acyloxy group in its anionic form. The steroid name is formed by replacing the terminal -e of the hydrocarbon name by yl, -diyl, etc. and inserting this before the locant with a Greek letter to designate position and configuration. When necessary locants should be used with the anionic part of the name. Examples:
Sa-Cholestan-Spy1 acetate Sp-Cholestane-3a, 12a-diyl diacetate 3-Oxoandrost-4-en-17pyl acetate (trivial name testosterone acetate) 17a-Hydroxy-20-oxopregn-5-en-3a-yl sulfate 12a-Hydroxy-5p-cholestan-3a-yl benzoate The prefix form acyloxy-, with the appropriate locants, is used if there is a preferred functional group as the suffix (e.g. an acid or lactone). Examples: 3a-Acetoxy-Spcardanolide 3a- Benzoyloxy-1 l~hydroxy-20-oxo-5~pregnan-2l-oate (monobenzoate of 47) 3pAcetoxyJa-cholano-24,17-lactone (acetate of 52)
When the steroid acid has a trivial name that already specifies the hydroxyl group that is esterified, the prefix must be 0-acyl-.Examples:
If it is wanted to emphasize the unesterified form of the steroid (e.g. in an index) the polyol may be named with the ester groups indicated as in the example 55 S~-cholestane-3a,12a-diol 12-acetate 3-benzoate. This style was recommended in the previous edition of these recommendations, but does not follow standard systematic nomenclature rules [3] .
2) In the case of simple sterols with trivial names, the substituent form of the trivial name may be used (e.g. cholesteryl linoleate). This form should not be used with polyols. 38-4.4. 0x0 compounds a) Aldehydes are named by using either the suffix -al (denotes change of -CH3 to -CHO, i.e. without change in the number of carbon atoms), or -aldehyde (denotes change of -COOH to -CHO, i.e. without change in the number of carbon atoms; the name is derived from that of the acid). The prefix 0x0-denotes the change of XH2 to XO, thus also of -CH3 to -CHO, with no change in the number of carbon atoms. Examples:
Sa-Androstan-19-a1 Sa-Cholan-24-al H
3 a,7 a, 12 a-Trih ydroxy -5p-cholan-24-a1 or cholaldehyde (from cholic acid) If the aldehyde group is formed by substitution of a hydrogen atom in X H , )CH2 or-CH3 by -CHO i.e. X -C H O the prefix formyl or suffix carbaldehyde is used. Examples:
3pFormyl-Sa-cholan-24-0ic acid H (58) 5pAndrostane-17pcarbaldehyde b) For ketones, the suffix is -one, and the prefix 0x0-. Examples:
SpAndrostan-3-one Pregn-S-ene-3,2O-dione 11-0xo-5a-cholan-24-oic acid Notes 1) The prefix 0x0-should also be used in connection with generic terms, e.g. 17-0x0 steroids. The term "l7-keto steroids", often used in the medical literature, is incorrect because C-17 is specified twice, as the term keto denotes C=O.
2) Many steroids cany hydroxyl groups as well as 0x0 groups. In this case, the suffix -one must be used, and hydroxyl groups indicated by prefixes, unless the compounds have trivial names (see Table 2 ). If the principal functional group (and hence the suffix) is preferred to either hydroxyl or 0x0 groups both hydroxyl and 0x0 groups are indicated as prefixes. 38-4.5. Alcohols Alcohols are named with the suffix -01 or the prefix hydroxy-, with the appropriate locants. Examples: SpCholestane-3a,l lpdiol 3a-Hydroxy-Sa-androstan-17-one (trivial name: androsterone) COO-Na' HO'* H
Sodium 3 a, 12a-dihydroxy-5~-cholan-24-oate common name: sodium 7-deoxycholate Notes not permitted by IUPAC Recommendations [3] and should not be used.
33-4.6. Amines 1) Composite suffixes -olone and -onol, to denote simultaneous presence of hydroxyl and ketonic groups, are 2) A few trivial names exist for hydroxy ketones (see Table 2 ).
Amines are named by means of the suffix -amine or the prefix amino-. Examples: Examples of trivial names retained for important steroid derivatives, these being mostly natural compounds of significant biological activity, are given in Table 2 .
Note
If these trivial names are used as a basis for naming derivatives or stereoisomers, the derived trivial name must make the nature of the modification completely clear and is preferably accompanied at first mention by the full systematic name. For example, in steroid papers epi is often used with trivial names to denote inversion at one centre; the name 11-epicortisol defines the compound fully since cortisol is already defined as the 1 l/Mcohol; but the name epicortisol does not define the compound and is inadequate.
33-4.10. Use of international non-proprietary names
International non-proprietary names (INNS) have been given to many steroids of pharmaceutical importance [6] . For convenience, a selection of some of these names is given in the appendix. If these names are used in biochemical papers, it is recommended that once in the paper, e.g. in a footnote or under Materials and Methods, the full systematic name is also given. International non-proprietary names should not be used as a basis for the names of modified compounds. 33-5. STEREOCHEMICAL MODIFICATIONS 33-5.1. Use of theprefur entIf, as for instance in a synthetic compound, there is stereochemical inversion at all the asymmetric centres whose configurations need not be specified in a name, the italicized prefix ent-(a contracted form of enantio-) is placed in front of the complete name of the compound. This prefix denotes inversion at all asymmetric centres (including those due to named substituents) whether these are cited separately or are implied in the name.
2~~,3a-(Methylenedioxy)pregn-S-ene (see 101)
Examples:
Thus, e.g. compound 64 above may be designated ent-63. 2) A compound with excessive modification of the steroid skeleton usually is best described by a systematic name. It is recommended that no more than two of the steroid rings be altered by any combination of the prefixes homo-and nor-. 33-7.5. Use of theprejix abeoAs an alternative to the application of nor-and homo-to the same molecule, the abeo system may sometimes be used. A compound that may be considered to arise from a steroid by bond migration may be given the name laid down in the preceding Recommendations for the steroid in question, to which is attached a prefix of the form x(y+z)abeo-. This prefix is compiled as follows: a numeral denoting the stationary (unchanged) end of the migrating bond (x) is followed by parentheses enclosing (i) the number denoting the original position 6 ) from which the other end of this bond has migrated, (ii) an mow, and (iii) the number ( z ) denoting the new position to which the bond has moved (see formulae 87a and 87b).
6
A (87a) (87b) (87b) The original numbering is retained for the new compound and is used for the numbers x, y and z. It is always necessary to specify the resulting stereochemistry. Examples: The abeo nomenclature described in this Recommendation is permissive, not compulsory. It is most suitable for use in discussions of reaction mechanism and biogenesis. For registration in a general (non-steroidal) compendium, the general systematic names, or names assigned by the homo-or nor-method, may be preferable. Thus 88 is identical with 86.
2) The abeo system has the advantage that the normal numbering of the steroid skeleton is retained. An examule is 89, the parent structure of some steroid alkaloids. Also, 84 maybe named 9(10+19)abe0-5a,lOa(H)-pregn~ne, C-9a remaining C-19. The stereochemical steroid descriptors a and p apply only when the remaining rings of a seco-compound are oriented as in the parent steroid, but not to alternative conformations (see formulae 92a and 92b). It is therefore recommended that after fission of ring B the stereochemistry of substituents on ring A is indicated by the R,S convention and a and p are restricted to rings C and D. Likewise after fission of ring C the stereochemistry of substituents on ring D is indicated by the R,S convention and a and p are restricted to rings A and B. 3s-9.0. General A 3s-9. VITAMIN D GROUP By far the most important seco-steroids are the D vitamins and their derivatives. They can be named according to Recommendation 3s-8.1, but this results in very cumbersome names. For this reason and for the benefit of biochemists, a set of trivial names has been proposed [5] , which can also be used as stem names for modified compounds. These names are permissive, not compulsory; authors may prefer to use the systematic seco-steroid names, which may indeed be more convenient for complicated structures.
